Barron's Live
Join Barron’s for an exclusive live conversation with journalists and guests. Our editors and reporters will examine the pandemic and its impact on markets, the economy, companies and individuals. Topics include Managing Your Money, The Future of Health Care, What to Watch in the Markets, Tech Stocks, and more.
Latest episodes
May 6, 2024 • 41min
Monetary Policy, Markets, and Mayhem
Barron's Deputy Editor Ben Levisohn, Associate Editor Al Root and Ironsides Macroeconomics Managing Partner Barry Knapp discuss the impact of Fed policy, economic growth, and inflation on the markets, and how investors should manage through the current turbulence.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Apr 22, 2024 • 45min
Investing in Real Estate and REITs
Barron's Senior Managing Editor, Senior Writer, and Baron Funds' Vice President discuss investing in real estate and REITs, exploring undervaluation of public real estate securities, navigating current economic landscape, diversified real estate fund strategies, comparing private funds with public REITs, and implications of the 2024 election on the real estate market.
Apr 15, 2024 • 43min
The Ins and Outs of Asset Allocation
Barron's Senior Managing Editor, Deputy Editor, and GMO's Co-Head of Asset Allocation discuss market reactions to geopolitical events, challenges of active management, financial performance of major banks, optimizing asset allocation, and insights on energy stocks and Treasuries in uncertain markets.
Apr 8, 2024 • 40min
What to Watch in the Markets this Week
Barron's Senior Managing Editor Lauren R. Rublin and Deputy Editor Ben Levisohn discuss the outlook for financial markets, industry sectors, and individual stocks.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Apr 1, 2024 • 44min
Around the World with Permanent Portfolio's Michael Cuggino
Barron's Senior Managing Editor Lauren R. Rublin, Deputy Editor Ben Levisohn and President and Portfolio Manager of Permanent Portfolio Family of Funds Michael Cuggino discuss the outlook for financial markets, industry sectors, and individual stocks around the world.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mar 25, 2024 • 40min
What to Watch in the Markets this Week
Barron's Senior Managing Editor and Deputy Editor discuss Fed interest rate cuts, market responses, corporate earnings forecasts, RH's stock outlook, strategic money allocation, undervalued stocks, and US housing market trends.
Mar 18, 2024 • 42min
Talking Markets with CIBC's David Donabedian
Discussing recent market rallies, uncertainties, and global bull market; Insights on stock market trends and Fed expectations; Micron Technology's earnings and semiconductor industry trends; Analysis of Nike and FedEx earnings reports; Balancing value and growth stocks in portfolios; Market analysis, economic trends, and differences between Canadian and US equity markets.
Mar 11, 2024 • 43min
What to Watch in the Markets this Week
Barron's senior managing editor Lauren R. Rublin and deputy editor Ben Levisohn discuss the outlook for financial markets, industry sectors, and individual stocks.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mar 4, 2024 • 43min
Talking Stocks with J. Stern & Co.'s Christopher Rossbach
Barron's senior managing editor Lauren R. Rublin, deputy editor Ben Levisohn and Christopher Rossbach, chief investment officer of J. Stern & Co. discuss the outlook for financial markets, industry sectors, and individual stocks.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Feb 26, 2024 • 43min
Opportunities in Healthcare Investing
Andy Acker, a portfolio manager at Janus Henderson Investors, dives into the dynamic world of healthcare investing. He explores the post-pandemic recovery of healthcare stocks, emphasizing innovation as a driver for future opportunities. Acker highlights the booming obesity market and emerging drug therapies in biotech, while also navigating the complexities of patient access and rising costs. The conversation turns to cutting-edge pneumococcal vaccine developments, showcasing leaders like Pfizer, and discusses how AI is reshaping medical investments.
